Science Saturday: Novel suppression-replacement preclinical gene therapy study shows promise in long and short QT syndromes
In a new study published in Circulation: Genomics& Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting both long QT syndrome (LQTS) and short QT syndrome (SQTS). LQTS is a genetic heart disease that can potentially cause fast, chaotic heartbeats. These rapid heartbeats might trigger people to faint suddenly. Some people with this disease have abnormal heart rhythm-mediated seizures and sudden cardiac arrest. In some severe cases, LQTS can cause sudden…
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news
More News: Cardiology | Databases & Libraries | Gene Therapy | Genetics | Heart | Heart Disease | Long QT Syndrome | Science | Study